Google expands AI mammography deal with iCAD
The amendment expands the original licensing agreement to 20 years and could allow the AI system to serve as a second reader.
The amendment expands the original licensing agreement to 20 years and could allow the AI system to serve as a second reader.
Regulators lowered enrollment minimums for accountable care organizations in the program, which allows providers to form groups to manage care and costs for fee-for-service Medicare enrollees.
Insulet filed the lawsuit as competitor Medtronic plans to buy EOFlow for $738 million.
Insulet claims EOFlow copied patch-pump design in patent suit Read More »
Amazon began automatically applying manufacturer coupons for some drugs in March, and is now adding new discounts for diabetes-related products.
Amazon Pharmacy expands insulin manufacturer coupons Read More »
A whistleblower accused Medtronic of violating the False Claims Act by billing the government for unnecessary medical procedures.
Medtronic’s bid to dismiss heart device kickback claims fails, clearing case to advance Read More »
Propanc Biopharma, Inc. today announced that the Company will target the Peter Mac Cancer Center in Melbourne, Australia, as the site for the First-In-Human (FIH) study for PRP in patients with advanced solid tumors.
Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its HLA-LOH assay as a companion diagnostic (CDx) test.
FDA Grants Breakthrough Device Designation To Tempus’ HLA-LOH Companion Diagnostic Test Read More »
Medicus IT, a trailblazer in healthcare technology solutions, proudly announces the appointment of Emily Sorrick as Chief People Officer.
The Boston-based health system posted an improvement in revenue and operating income after it was placed on a financial improvement plan by the state last year.
Mass General Brigham posts positive operating margin in Q3 after high 2022 losses Read More »
Viseon Inc. Announces Commercial Rollout and Initial Clinical Use of the 4K MaxView ® System for Advanced Digital Visualization during Minimally Invasive Spine Surgery.